News About: Pharm. Industry
How listed pharmas’ holding companies did with their 2017 report cards?
Although holding companies of listed pharmaceutical companies have reportedly achieved satisfactory performances in sales and operating profits last year, but had net profits that are similar to the year before.
Yaku...
Multinational pharma products going out-of-stock due to supply delays from overseas manufacturing facilities
Supply of multinational pharmaceutical company products continue to experience out-of-stock due to supply delays from their overseas manufacturing facilities.
Products that went out-of-stock by the supply delay are P...
Celltrion Group Chairman Jung-Jin Seo leading local marketing activities in Europe
Celltrion Group Chairman Jung-Jin Seo is commanding the company’s marketing activities in person as visiting each European country for about 2 months – he left Korea this March – to enlarge market shares of antibody b...
Listed pharmas serious with weakened profitability with 7.7% average operating profit rate
Listed pharmaceutical companies are experiencing weakened profitability and severe polarization.
While there are 11 pharmaceutical companies with an average operating profit rate higher than 15% for the past 3 years,...
Dong-A’s ‘Twolion’ preoccupies market after Talion’s patent expiration
In the last year’s antihistamine market where Korean pharmaceutical companies are having fierce competition after the Talion’s patent expiration in Korea, Dong-A Pharm’s Twolion is reportedly cruising smoothly.
After...
20 listed pharmas including MyungMoon and Jin Yang with over 40% SG&A expense percentage
20 listed pharmaceutical companies, like MyungMoon Pharm and Jin Yang Pharmaceutical, spent SG&A(selling, general & administrative) expenses accounting for over 40% of the total sales. The SG&A expenses percentage tha...
1 of 2 listed pharmas record decrease of net profits or losses
Although listed pharmaceutical companies recorded a business performance that is closed to the last year’s average, 1 of 2 pharmaceutical companies reportedly had lower net profits, showing that they are having diffic...
Listed pharmas had about same sales increase, but profit gap has gotten worse
While listed pharmaceutical companies reportedly recorded a sales increase rate that is similar to the average of the last year, they had the serious polarization of profits.
Yakup Shinmoon(www.yakup.com) analyzed s...
Nibec acquires approval of medical devices in Israel
As acquiring approval of medical devices in Israel, Nibec, a health care company specializing in peptide, will now be able to enter the global medical device market, including not only the U.S. and Europe, but the Mid...
GC Pharm acquires approval of ‘Glargia’ referencing insulin glargine
GC Pharm(CEO Eun-Cheol Huh) announced on the 9th that the company acquired approval of ‘Glargia(insulin glargine),’ an antidiabetic biosimilar(bioequivalently tested) from the Ministry of Food and Drug Safety.
The or...
